[APD-3] Status of maintenance in B-cell lymphoma management
Prof Won-Seog Kim is a Professor of Division of Hematology-Oncology at Samsung Medical Center and in charge of malignant lymphoma service. He is working as a chairman of lymphoma working party of Korean Society of Hematology and consortium for improved survival of lymphoma (CISL). He is also one of the founding members of Asian Lymphoma study group (ALSG). He is now co-chairing of T-cell lymphoma forum.
Malignant lymphoma is Prof Kim’s area of special interest. Recently, he is much more focus on the management of T or NK/T-cell lymphomas and new compounds. He has published more than 280 peer-reviewed articles on clinical research in malignant lymphoma. His award achievements include Outstanding Research Award from Korean Society of Hematology (2010), Best Achievement in inpatient care (2006) and in Research (2007) from Samsung Medical Center, and Outstanding senior researcher award from Korean society of hematology (2016).
Malignant lymphoma is Prof Kim’s area of special interest. Recently, he is much more focus on the management of T or NK/T-cell lymphomas and new compounds. He has published more than 280 peer-reviewed articles on clinical research in malignant lymphoma. His award achievements include Outstanding Research Award from Korean Society of Hematology (2010), Best Achievement in inpatient care (2006) and in Research (2007) from Samsung Medical Center, and Outstanding senior researcher award from Korean society of hematology (2016).
抄録パスワード認証
パスワードは「第80回日本血液学会学術集会 プログラム抄録集のプログラム検索・スケジュール登録アプリのご案内ページ」に記載してあります。